Best Practices in Lung Cancer
Our panel of experts will be discussing the Targeted Therapy for ALK-mutated NSCLC and the Therapeutic Options for R/R ROS1 Mutated NSCLC.
Our panel of experts will be discussing the Targeted Therapy for ALK-mutated NSCLC and the Therapeutic Options for R/R ROS1 Mutated NSCLC.
Relapsed/Refractory Multiple Myeloma
CAR-T
Bispecific Antibodies